Casey W M, Nguyen N A
GlaxoWellcome, Inc., Research Triangle Park, NC 27709, USA.
PDA J Pharm Sci Technol. 1996 Nov-Dec;50(6):352-5.
E. coli strain HB101 was genetically engineered to a fluorescent phenotype by transformation with a plasmid containing complementary DNA for a green fluorescent protein. The level of fluorescence in the transformed strain was directly proportional to the number of viable cells. There was a rapid decrease in fluorescence when transformed cells were inoculated into lamivudine solutions containing ten different preservative formulations. The decrease in fluorescence correlated to a decrease in the number of viable cells, allowing the relative antimicrobial properties of each solution to be compared. This methods provides a simple, rapid (< 2 min/assay), and accurate means of determining the effects of antimicrobial solutions on the viability of E. coli.
通过用含有绿色荧光蛋白互补DNA的质粒转化,将大肠杆菌HB101菌株改造为荧光表型。转化菌株中的荧光水平与活细胞数量直接成正比。当将转化细胞接种到含有十种不同防腐剂配方的拉米夫定溶液中时,荧光迅速下降。荧光的下降与活细胞数量的减少相关,从而可以比较每种溶液的相对抗菌特性。该方法提供了一种简单、快速(每次测定<2分钟)且准确的手段来确定抗菌溶液对大肠杆菌活力的影响。